Market revenue in 2023 | USD 22.2 million |
Market revenue in 2030 | USD 29.7 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Dna phosphoramidites |
Fastest growing segment | RNA Phosphoramidites |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | DNA Phosphoramidites, RNA Phosphoramidites, Labeled Phosphoramidites, Modifier Phosphoramidites |
Key market players worldwide | BOC Sciences, Thermo Fisher Scientific Inc, Merck KGaA, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, LGC Group, Biosynth, Bioneer, Qiagen NV, PolyOrg, Lumiprobe |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to phosphoramidite market will help companies and investors design strategic landscapes.
Dna phosphoramidites was the largest segment with a revenue share of 36.49% in 2023. Horizon Databook has segmented the Middle East & Africa phosphoramidite market based on dna phosphoramidites, rna phosphoramidites, labeled phosphoramidites, modifier phosphoramidites covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa phosphoramidite market, including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa phosphoramidite market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account